STOCK TITAN

CVI and Heights disclose 3.8% Pasithea (KTTA) stake via warrant holdings

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Pasithea Therapeutics Corp. received an updated ownership report from institutional investors CVI Investments, Inc. and Heights Capital Management, Inc. The Reporting Persons state beneficial ownership of 899,994 shares of Pasithea common stock, representing 3.8% of the outstanding shares as of the referenced date.

The position consists of shares issuable upon exercise of warrants, which are subject to a 9.99% beneficial ownership limitation that caps how many shares can be acquired at any time. Pasithea’s definitive proxy indicates 23,091,062 shares of common stock were outstanding as of December 22, 2025, providing context for the reported 3.8% stake.

CVI Investments, Inc. is organized in the Cayman Islands and Heights Capital Management, Inc. in Delaware. Heights acts as investment manager to CVI and may exercise voting and dispositive power over the reported shares, while both parties disclaim beneficial ownership beyond their economic interest.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: With respect to Row 6 and Row 8 above, Heights Capital Management, Inc. is the investment manager to CVI Investments, Inc. and as such may exercise voting and dispositive power over the shares reported as beneficially owned by CVI Investments, Inc. herein.


SCHEDULE 13G




Comment for Type of Reporting Person: With respect to Row 6 and Row 8 above, Heights Capital Management, Inc. is the investment manager to CVI Investments, Inc. and as such may exercise voting and dispositive power over the shares reported as beneficially owned by CVI Investments, Inc. herein.


SCHEDULE 13G



CVI Investments, Inc.
Signature:/s/ Sarah Travis
Name/Title:Sarah Travis, Assistant General Counsel and Assistant Secretary of Heights Capital Management, Inc.
Date:02/10/2026
Heights Capital Management, Inc.
Signature:/s/ Sarah Travis
Name/Title:Sarah Travis, Assistant General Counsel and Assistant Secretary
Date:02/10/2026

Comments accompanying signature: Heights Capital Management, Inc. serves as authorized agent of CVI Investments, Inc. pursuant to a Limited Power of Attorney, a copy of which was previously filed.
Exhibit Information

EXHIBIT INDEX EXHIBIT DESCRIPTION 24 Limited Power of Attorney* 99 Joint Filing Agreement* * Previously filed

FAQ

What ownership stake in Pasithea Therapeutics Corp. (KTTA) is reported in this Schedule 13G/A amendment?

The filing reports beneficial ownership of 899,994 Pasithea common shares, equal to 3.8% of the class. This stake is based on warrants exercisable into common stock and a disclosed 23,091,062 outstanding shares as of December 22, 2025.

Who are the reporting persons in the Pasithea Therapeutics Corp. (KTTA) Schedule 13G/A?

The reporting persons are CVI Investments, Inc. and Heights Capital Management, Inc. CVI is organized in the Cayman Islands, while Heights is a Delaware entity that serves as investment manager to CVI and may exercise voting and dispositive power over the reported shares.

How is the 3.8% ownership of KTTA common stock calculated in this filing?

The 3.8% figure is based on 899,994 shares deemed beneficially owned relative to 23,091,062 Pasithea shares outstanding. The outstanding share count comes from Pasithea’s definitive proxy statement, which states that total as of December 22, 2025.

What kind of securities do CVI and Heights hold in Pasithea Therapeutics Corp. (KTTA)?

The reported beneficial ownership consists of shares issuable upon exercise of warrants to purchase Pasithea common stock. These warrants are structured so they cannot be exercised if doing so would push the holder’s beneficial ownership above a 9.99% threshold.

What does the 9.99% beneficial ownership limitation mean for KTTA warrants?

The 9.99% limitation means the warrants cannot be exercised if that would cause total beneficial ownership of Pasithea shares, including affiliates and aggregated persons, to exceed 9.99%. This provision restricts how many shares can be acquired through warrant exercise at any given time.

Does Heights Capital Management directly own KTTA shares or act in another capacity?

Heights Capital Management acts as investment manager to CVI Investments, Inc. and may be deemed to beneficially own the shares held by CVI. Both reporting persons disclaim beneficial ownership of any shares beyond their pecuniary, or economic, interest in those securities.

What certification do the reporting persons make about their KTTA holdings?

They certify the securities were not acquired and are not held for the purpose of changing or influencing control of Pasithea. They also state the holdings are not part of any transaction with that purpose, other than activities solely connected with a nomination under Rule 14a-11.
Pasithea Therapeutics Corp

NASDAQ:KTTA

KTTA Rankings

KTTA Latest News

KTTA Latest SEC Filings

KTTA Stock Data

16.40M
3.28M
Biotechnology
Pharmaceutical Preparations
Link
United States
MIAMI BEACH